Minneapolis-based Fasikl has received FDA 510(k) clearance for its Felix NeuroAI Wristband for adults with essential tremor. The wearable combines AI and neurotechnology to modulate the nervous system to help alleviate functional limitations caused by…
Continue Reading
Escala Medical, a technology company specializing in the treatment of pelvic organ prolapse, has secured $4.5 million in funding.EIC Fund led the round, which follows a $2.9 million (€2.5 million) grant awarded to Escala…
Continue Reading
Dr. Scott Schell, Chief Medical Officer, Cognizant
As cyber threats become increasingly sophisticated, proposed updates to federal healthcare cybersecurity standards have reignited debate across the industry. Introduced in December 2024, these regulations represent the first…
Continue Reading
Background: Cataract is the world’s leading cause of avoidable blindness. High-quality cataract surgery is a cost-effective procedure to restore vision. In low- and middle-income countries (LMIC), there are high rates of poor outcomes after…
Continue Reading
Nursing takes strength. But it also takes rest. 💙In this video, nursing professionals—and proud HIMSS members—share the personal routines that help them unwind and restore.Take a moment to listen, and let it be a…
Continue Reading
Elon Musk’s brain-computer interface (BCI) implant startup Neuralink has filed applications with the United States Patent and Trademark Office (USPTO) to trademark the terms “Telepathy,” “Blindsight,” and “Telekinesis.” The applications, filed in early March, pertain…
Continue Reading
Dr. Scott Spiro, a board-certified plastic surgeon with nearly 30 years of expertise in advanced cosmetic and reconstructive surgeries with a private practice based in West Orange, New Jersey again joins eHealth Radio and…
Continue Reading
A cyber attack has forced a US non-profit blood donor centre to postpone appointments despite declaring blood shortages just one week earlier.
New York Blood Center Enterprises announced that it had “identified suspicious activity” affecting…
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
Neurotechnology company, Grey Matter Neurosciences, announced it secured $14 million in seed financing, which will be used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials.The…
Continue Reading
